Clinical Trial

Kinesiophobia, Fear of Falling, Functional Independence, and Psychological Status in Spinal Cord Injury

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 24, 2026 (before its estimated June 20, 2026 completion). Its status may not reflect the trial's current state.
Summary
Individuals aged 18-65 years who have been clinically diagnosed with spinal cord injury and have developed paraplegia will be included in the study. Demographic and clinical data of the participants, including age, sex, height, weight, etiology of injury, level of injury, duration of injury, and comorbidities, will be recorded. In addition, disease-specific characteristics such as ambulation status, wheelchair use, presence of incontinence, and presence and severity of pain will be assessed. Kinesiophobia levels of the patients will be evaluated using the Tampa Scale for Kinesiophobia (TSK). Functional independence will be assessed using the Spinal Cord Independence Measure-III Self-Report (SCIM-III SR). Fall-related concerns will be evaluated using the Spinal Cord Injury-Falls Concern Scale (SCI-FCS). Pain severity will be assessed using the Visual Analog Scale (VAS), and the presence of neuropathic pain will be evaluated using the DN4 Neuropathic Pain Questionnaire. Symptoms related to anxiety and depression will be assessed using the Hospital Anxiety and Depression Scale (HADS). All assessments will be conducted through face-to-face interviews. The collected data will be analyzed to investigate the relationship between kinesiophobia and functional independence, fear of falling, pain, and psychological status in individuals with paraplegic spinal cord injury. Validated Turkish versions of all scales used in the study will be employed.
Trial Details
NCT Number NCT07549217
Lead Sponsor Istanbul Physical Medicine Rehabilitation Training and Research Hospital
Conditions Spinal Cord Injuries
Enrollment 70 participants
Start Date 2026-05-20
Primary Completion 2026-06-20 (estimated)
Study Completion 2026-06-20 (estimated)
Updated on ClinicalTrials.gov 2026-04-24